Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-Label, Multi-Dose Crossover Study Assessing the Pharmacokinetic Profiles of Diazoxide Choline [diazoxide] Coated Versus Uncoated Formulations in Healthy Volunteers.

Trial Profile

A Randomized, Open-Label, Multi-Dose Crossover Study Assessing the Pharmacokinetic Profiles of Diazoxide Choline [diazoxide] Coated Versus Uncoated Formulations in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2018

At a glance

  • Drugs Diazoxide (Primary)
  • Indications Prader-Willi syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Oct 2018 Results from this study were presented at the 57th Annual European Society for Paediatric Endocrinology (ESPE).
    • 08 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 08 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top